FDA Accepts Orasis Pharmaceuticals ’ New Drug Application for CSF-1 for the Treatment of Presbyopia

Investigational, novel eye drop candidate was assigned PDUFA goal date of October 22, 2023 Ponte Vedra, FL, February 21, 2023– Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news